Frequently Asked Questions About BioNTech SE (BNTX) Stock
BioNTech SE's (BNTX) last reported annual revenue was USD 3.82 Billion.
BioNTech SE's (BNTX) annual revenue growth rate based on the revenue reported in the past 5 years is : 97.35%
BioNTech SE's(BNTX) is profitable as of its last reported annual financials.
The net profit margin for BioNTech SE's(BNTX) from its laster reported year is 24.36%
The return on equity (ROE) for BioNTech SE's(BNTX) from its last reported annual financials is : N/A
The return on assets (ROA) for BioNTech SE's(BNTX) from its last reported annual financials is : N/A
The return on invested capital (ROIC) for BioNTech SE's(BNTX) from its last reported annual financials is : N/A
The Debt to Equity ratio for BioNTech SE's(BNTX) from its last reported annual financials is : N/A
The dividend yield for BioNTech SE's(BNTX) from its laster reported year is N/A
BioNTech SE's(BNTX) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for BNTX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
